Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

Purpose. In 2018, the US Preventive Services Task Force (USPSTF) endorsed three strategies for cervical cancer screening in women ages 30 to 65: cytology every 3 years, testing for high-risk types of human papillomavirus (hrHPV) every 5 years, and cytology plus hrHPV testing (co-testing) every 5 yea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MDM Policy Pract
Hauptverfasser: Holt, Hunter K., Kulasingam, Shalini, Sanstead, Erinn C., Alarid-Escudero, Fernando, Smith-McCune, Karen, Gregorich, Steven E., Silverberg, Michael J., Huchko, Megan J., Kuppermann, Miriam, Sawaya, George F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440733/
https://ncbi.nlm.nih.gov/pubmed/32885045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468320952409
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge